Diagnos Inc (ADK_CDNX)
ADK_CDNX moved a median of 0.00% 30 minutes after news, and -1.46% by the close. How ADK_CDNX actually reacts to news — the realized, point-in-time move the market made, measured across 81 labeled events over the last three years with zero look-ahead.
ADK_CDNX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 18% | 17 |
| 30-min | 0.00% | 27% | 22 |
| 60-min | 0.00% | 26% | 23 |
| to close | -1.46% | 19% | 26 |
| Middle 50% of ADK_CDNX reactions | -1.48% to +1.07% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 81 |
Half of all Diagnos Inc news events land between -1.48% and +1.07% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when ADK_CDNX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ADK_CDNX's baseline. Nothing else.
Recent ADK_CDNX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| DIAGNOS Provides an Update on Stock Warrants | Press release | GlobeNewswire | — | — | |
| DIAGNOS Advances Regulatory Strategy with US FDA Submission for CARA System | Press release | GlobeNewswire | — | — | |
| DIAGNOS to Hold its Annual General Meeting of Shareholders on September 30, 2026 | Press release | GlobeNewswire | — | — | |
| Canadian Investment Regulatory Organization Trade Resumption - ADK | Press release | Canada Newswire | — | — | |
| Canadian Investment Regulatory Organization Trading Halt - ADK | Press release | Canada Newswire | — | — | |
| DIAGNOS Receives Saudi FDA Medical Device License for CARA System, Bringing AI-Assisted Retinal Image Analysis to Saudi Arabia | Press release | GlobeNewswire | — | — | |
| Canadian Investment Regulatory Organization Trade Resumption - ADK | Press release | Canada Newswire | — | — | |
| Canadian Investment Regulatory Organization Trading Halt - ADK | Press release | Canada Newswire | — | — | |
| DIAGNOS Receives Health Canada Medical Device Licence for CARA System, Bringing AI-Assisted Retinal Image Analysis to Canadian Optometrists | Press release | GlobeNewswire | — | — | |
| DIAGNOS to Extend the Exercise Period of Stock Warrants | Press release | GlobeNewswire | — | — | |
| DIAGNOS Announces Shares for Debt Settlement | Press release | GlobeNewswire | — | — | |
| DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform | Press release | GlobeNewswire | — | — | |
| DIAGNOS Announces Grant of Stock Options and Adoption of Semi-Annual Reporting | Press release | GlobeNewswire | — | — | |
| Presenting on Emerging Growth Conference 93 Day 1 on June 10; Register to live stream | Press release | GlobeNewswire | — | — | |
| Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform | Press release | GlobeNewswire | — | — | |
| DIAGNOS to Present at the Emerging Growth Conference on June 10, 2026 | Press release | GlobeNewswire | — | — | |
| DIAGNOS Announces Amendment to Convertible Debentures | Press release | GlobeNewswire | — | — | |
| DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA | Press release | GlobeNewswire | — | — | |
| DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration | Press release | GlobeNewswire | — | — | |
| DIAGNOS Announces Amendments to Convertible Debentures and Stock Warrants | Press release | GlobeNewswire | — | — | |
| DIAGNOS to present at Centurion One Capital 9th Annual Toronto Growth Conference | Press release | GlobeNewswire | — | — | |
| DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation | Press release | GlobeNewswire | — | — | |
| DIAGNOS Announces the Engagement of IBN | Press release | GlobeNewswire | — | — | |
| DIAGNOS Advances Regulatory Strategy for CARA in Key Markets: Updates on Health Canada, FDA, and SFDA Progress | Press release | GlobeNewswire | — | — | |
| DIAGNOS Appoints Dr. Ismail Ben Ayed as Chief Artificial Intelligence (AI) Scientist to Accelerate our Innovation in Healthcare | Press release | GlobeNewswire | — | — | |
| DIAGNOS Strengthens Governance and Leadership with the Appointment of Philippe Couillard as Chairman of the Board of Directors | Press release | GlobeNewswire | — | — | |
| DIAGNOS Welcomes Dr. Pierre-Luc Charlebois to its Advisory Board | Press release | GlobeNewswire | — | — | |
| DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on November 9, 2025 | Press release | GlobeNewswire | — | — | |
| Validated for Global Scale: DIAGNOS Passes Annual MDSAP Audit, Solidifying the Pathway to Approvals with Health Canada & FDA | Press release | GlobeNewswire | — | — | |
| DIAGNOS Announces Voting Results of Meeting of Shareholders | Press release | GlobeNewswire | — | — | |
| DIAGNOS Announces Closing of Private Placement | Press release | GlobeNewswire | — | — | |
| DIAGNOS Announces Private Placement | Press release | GlobeNewswire | — | — | |
| DIAGNOS to Extend Stock Warrants Exercise Period | Press release | GlobeNewswire | — | — | |
| DIAGNOS Announces Extension of Stock Warrants Exercise Period | Press release | GlobeNewswire | — | — | |
| DIAGNOS Files FDA Pre-Submission for its CARA System: Strategic Entry into the U.S. Optometry Market with Support from ORA LLC | Press release | GlobeNewswire | — | — | |
| DIAGNOS Welcomes Veteran Optometrist Dr. Barry A. Ginsberg to its Scientific Advisory Board for the United States | Press release | GlobeNewswire | — | — | |
| DIAGNOS Welcomes Founder of National Vision Associates, Ed Weiner, to its Advisory Board for the United States | Press release | GlobeNewswire | — | — | |
| DIAGNOS Welcomes Former White House Economic Adviser Dr. Tomas J. Philipson to its Advisory Board for the US Market | Press release | GlobeNewswire | — | — | |
| DIAGNOS Announces the Engagement of Allele Capital Partners | Press release | GlobeNewswire | — | — | |
| DIAGNOS Announces Amendment to Convertible Debentures | Press release | GlobeNewswire | — | — | |
| DIAGNOS announces major advances in Cybersecurity certification by the Cyber Defense Operations Center (COCD) for its CARA System application | Press release | GlobeNewswire | — | — | |
| DIAGNOS Provides Additional Information on Amendment to Convertible Debentures | Press release | GlobeNewswire | — | — | |
| DIAGNOS Provides Update on its Health Canada Medical Device Licence Application | Press release | GlobeNewswire | — | — | |
| DIAGNOS Announces Amendment to Convertible Debentures | Press release | GlobeNewswire | — | — | |
| DIAGNOS Opens First US Office in Florida | Press release | GlobeNewswire | — | — | |
| DIAGNOS is filing for the Saudi FDA Authorization of Its CARA SYSTEM, an AI Assisted Medical Device | Press release | GlobeNewswire | — | — | |
| DIAGNOS Announces Amendment to Convertible Debentures | Press release | GlobeNewswire | — | — | |
| DIAGNOS to File for FDA Pre-Market Authorization of Its AI-Powered CARA SYSTEM and Engages Ora as Regulatory Specialist | Press release | GlobeNewswire | — | — | |
| Correction - Diagnos Announces Closing of Private Placement | Press release | GlobeNewswire | — | — | |
| DIAGNOS Announces Closing of Private Placement | Press release | GlobeNewswire | — | — |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ADK_CDNX section they belong to.
Where else ADK_CDNX is measured.
ADK_CDNX earnings → · Analyst actions → · SEC filings →
Other Technology names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| JOYY Inc. - American Depositary Shares (YY) | 82 | +0.33% | 55% |
| ARCELIK A S UNSP/ADR (ACKAY) | 81 | 0.00% | 4% |
| CAMP4 Therapeutics Corporation (CAMP) | 81 | 0.00% | 48% |
| SQUARE ENIX HLDGS U/ADR (SQNNY) | 81 | 0.00% | 19% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Technology names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Diagnos Inc's median reaction calculated?
Every labeled ADK_CDNX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 81 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 27% of ADK_CDNX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does ADK_CDNX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.